ANDATOPICALGEL
Approved
Feb 2022
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
3/8 — Basic
CLINDAMYCIN PHOSPHATE AND TRETINOIN (clindamycin phosphate and tretinoin) by Solaris Biotech is clindamycin: [see microbiology (). Approved for retinoid [epc]. First approved in 2022.
Drug data last refreshed 18h ago
Mechanism of Action
Clindamycin: [See Microbiology ().] Tretinoin: Although the exact mode of action of tretinoin is unknown, current evidence suggests that topical tretinoin decreases cohesiveness of follicular epithelial cells with decreased microcomedone formation. Additionally, tretinoin stimulates mitotic…
Pharmacologic Class:
Retinoid
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
Worked on CLINDAMYCIN PHOSPHATE AND TRETINOIN at Solaris Biotech? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.